Shares of Johnson & Johnson rose by 0.68% on Thursday, ahead of the growth of the S&P 500 index by 0.32% after as the company announced that it plans to begin the final phase of a clinical trial of its COVID-19 vaccine in September. Shares of J&J recovered after losses in February and March and […]